ATE332136T1 - Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten - Google Patents
Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheitenInfo
- Publication number
- ATE332136T1 ATE332136T1 AT01900231T AT01900231T ATE332136T1 AT E332136 T1 ATE332136 T1 AT E332136T1 AT 01900231 T AT01900231 T AT 01900231T AT 01900231 T AT01900231 T AT 01900231T AT E332136 T1 ATE332136 T1 AT E332136T1
- Authority
- AT
- Austria
- Prior art keywords
- cadpr
- nicotinamide
- treatment
- agents
- skin diseases
- Prior art date
Links
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 title abstract 4
- 229960003966 nicotinamide Drugs 0.000 title abstract 2
- 235000005152 nicotinamide Nutrition 0.000 title abstract 2
- 239000011570 nicotinamide Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 title 1
- 208000017520 skin disease Diseases 0.000 title 1
- BQOHYSXSASDCEA-KEOHHSTQSA-N Cyclic ADP-Ribose Chemical compound C([C@@H]1[C@H]([C@H]([C@@H](O1)N1C=2N=CN3C(C=2N=C1)=N)O)O)OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H]3O1 BQOHYSXSASDCEA-KEOHHSTQSA-N 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 150000002266 vitamin A derivatives Chemical class 0.000 abstract 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL133976A IL133976A (en) | 2000-01-11 | 2000-01-11 | Agents for the treatment of skin disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE332136T1 true ATE332136T1 (de) | 2006-07-15 |
Family
ID=11073692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01900231T ATE332136T1 (de) | 2000-01-11 | 2001-01-09 | Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20030032617A1 (de) |
| EP (1) | EP1259240B8 (de) |
| AT (1) | ATE332136T1 (de) |
| AU (1) | AU782558B2 (de) |
| CA (1) | CA2396186C (de) |
| DE (1) | DE60121303T2 (de) |
| DK (1) | DK1259240T3 (de) |
| ES (1) | ES2267706T3 (de) |
| IL (2) | IL133976A (de) |
| WO (1) | WO2001051051A2 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090098065A1 (en) * | 2000-01-11 | 2009-04-16 | Avikam Harel | Composition and methods for the treatment of skin disorders |
| WO2003001985A2 (en) * | 2001-06-28 | 2003-01-09 | Dermtech International | Method for detection of melanoma |
| DE60308891T2 (de) | 2002-06-20 | 2007-05-24 | Astion Dermatology A/S | Neue komplexe von polyhydroxyalkanfettsäureestern und niacinamid |
| CA2492248A1 (en) * | 2002-07-11 | 2004-01-22 | Avikam Harel | Composition and methods for the treatment of skin disorders |
| US7357950B2 (en) | 2003-03-21 | 2008-04-15 | Elizabeth Anne Mazzio | Topical treatment for dyshidrosis (pompholyx) and dry skin disorders |
| US7666451B2 (en) | 2003-03-21 | 2010-02-23 | Elizabeth Anne Mazzio | Method of treating dyshidrosis(pompholyx) and related dry skin disorders |
| GB0403041D0 (en) | 2004-02-11 | 2004-03-17 | Milner Anne J | Induction of apoptosis |
| US7183057B2 (en) * | 2004-03-31 | 2007-02-27 | Dermtech International | Tape stripping methods for analysis of skin disease and pathological skin state |
| CN101193641B (zh) | 2005-05-10 | 2013-05-29 | 德米普瑟尔有限公司 | 用于治疗表皮过度增殖疾病的组合物和方法 |
| US8034788B2 (en) | 2005-05-10 | 2011-10-11 | Dermipsor Ltd. | Composition and methods for skin care |
| US20070183995A1 (en) * | 2006-02-09 | 2007-08-09 | Conopco, Inc., D/B/A Unilever | Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same |
| GB0619860D0 (en) * | 2006-10-06 | 2006-11-15 | Birkeland Innovasjon As | Treatment of insulin resistance and disorders associated therewith |
| US20080173558A1 (en) * | 2007-01-22 | 2008-07-24 | Contelanea Arvanitis | Fragrance-emanating nasal mask device and method |
| US20080274908A1 (en) * | 2007-05-04 | 2008-11-06 | Dermtech International | Diagnosis of melanoma by nucleic acid analysis |
| EP2626437A3 (de) | 2008-05-14 | 2013-12-11 | Dermtech International | Diagnose von Melanom und Sonnenpigmentflecken mittels Nucleinsäureanalyse |
| US20100086501A1 (en) * | 2008-08-28 | 2010-04-08 | Dermtech International | Determining Age Ranges of Skin Samples |
| JP6611099B2 (ja) * | 2015-05-01 | 2019-11-27 | ザ プロクター アンド ギャンブル カンパニー | 皮膚の健康を改善する方法及びそのための組成物 |
| WO2017004102A1 (en) | 2015-06-29 | 2017-01-05 | The Procter & Gamble Company | Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container |
| EP3236928B1 (de) | 2016-01-11 | 2020-12-09 | The Procter and Gamble Company | Verfahren zur behandlung einer hauterkrankung und zusammensetzungen dafür |
| WO2018237218A1 (en) | 2017-06-23 | 2018-12-27 | The Procter & Gamble Company | Composition and method for improving the appearance of skin |
| EP3752645A4 (de) | 2018-02-14 | 2022-04-13 | Dermtech, Inc. | Neue gen-klassifikatoren und deren verwendung bei nicht-melanom-hautkrebs |
| KR102069088B1 (ko) * | 2018-04-02 | 2020-01-22 | 양미경 | 탈모의 예방 또는 치료용, 또는 발모 또는 육모 촉진용 약학 또는 화장료 조성물 |
| EP3817717A1 (de) | 2018-07-03 | 2021-05-12 | The Procter & Gamble Company | Verfahren zur behandlung einer hautkrankheit |
| JP2022524641A (ja) | 2019-03-26 | 2022-05-09 | ダームテック，インク． | 皮膚癌における新規な遺伝子分類子とその使用 |
| US11685766B2 (en) | 2019-05-08 | 2023-06-27 | Creighton University | 14-3-3 targeting peptides for cancer treatment |
| US11518784B2 (en) | 2019-05-08 | 2022-12-06 | Creighton University | 14-3-3 targeting peptides for cancer treatment |
| JP7590462B2 (ja) | 2020-06-01 | 2024-11-26 | ザ プロクター アンド ギャンブル カンパニー | ビタミンｂ３化合物の皮膚への浸透を改善する方法 |
| US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4067975A (en) * | 1975-08-04 | 1978-01-10 | Yu Ruey J | Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide |
| US4505896A (en) * | 1979-04-19 | 1985-03-19 | Elorac, Ltd. | Method of treating acne vulgaris and composition |
| HU209067B (en) * | 1991-12-30 | 1994-03-28 | Tatar | Process for the production of hair-fall moderating preparation |
| DE4335454A1 (de) * | 1993-10-19 | 1995-04-20 | Schleicher Peter | Geriatrikum |
| US6248763B1 (en) * | 1998-05-19 | 2001-06-19 | Scivoletto Rosemarie | Composition for treating skin conditions |
| US6429218B1 (en) * | 1997-05-19 | 2002-08-06 | Joseph Scivoletto | Method of controlling niacin concentration in lotion |
| USH2013H1 (en) * | 1997-05-23 | 2002-02-05 | The Procter & Gamble Company | Skin care compositions |
| US6107349A (en) * | 1998-04-16 | 2000-08-22 | Mantynen; Philip R. | Method and composition for treating psoriasis |
| DE29916231U1 (de) * | 1999-09-15 | 2000-02-17 | Renner, Jobst, Dr., 81479 München | Multivitamin- und -mineralpräparat |
-
2000
- 2000-01-11 IL IL133976A patent/IL133976A/en not_active IP Right Cessation
-
2001
- 2001-01-09 DE DE60121303T patent/DE60121303T2/de not_active Expired - Lifetime
- 2001-01-09 AU AU23929/01A patent/AU782558B2/en not_active Ceased
- 2001-01-09 IL IL15070601A patent/IL150706A0/xx unknown
- 2001-01-09 DK DK01900231T patent/DK1259240T3/da active
- 2001-01-09 AT AT01900231T patent/ATE332136T1/de active
- 2001-01-09 CA CA2396186A patent/CA2396186C/en not_active Expired - Fee Related
- 2001-01-09 EP EP01900231A patent/EP1259240B8/de not_active Expired - Lifetime
- 2001-01-09 WO PCT/IL2001/000017 patent/WO2001051051A2/en not_active Ceased
- 2001-01-09 ES ES01900231T patent/ES2267706T3/es not_active Expired - Lifetime
-
2002
- 2002-07-11 US US10/192,842 patent/US20030032617A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20030032617A1 (en) | 2003-02-13 |
| EP1259240B1 (de) | 2006-07-05 |
| AU782558B2 (en) | 2005-08-11 |
| EP1259240A2 (de) | 2002-11-27 |
| DE60121303T2 (de) | 2007-06-14 |
| EP1259240B8 (de) | 2007-05-09 |
| HK1051497A1 (en) | 2003-08-08 |
| DK1259240T3 (da) | 2006-10-30 |
| IL133976A0 (en) | 2001-04-30 |
| IL133976A (en) | 2006-09-05 |
| IL150706A0 (en) | 2003-02-12 |
| DE60121303D1 (de) | 2006-08-17 |
| AU2392901A (en) | 2001-07-24 |
| WO2001051051A3 (en) | 2002-06-27 |
| CA2396186C (en) | 2011-03-22 |
| ES2267706T3 (es) | 2007-03-16 |
| WO2001051051B1 (en) | 2002-09-26 |
| CA2396186A1 (en) | 2001-07-19 |
| WO2001051051A2 (en) | 2001-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE332136T1 (de) | Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten | |
| IL154888A (en) | Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid | |
| DK1289517T3 (da) | Farmaceutiske sammensætninger indeholdende cannabidiolderivater | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| DK1032376T3 (da) | Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse | |
| ATE312635T1 (de) | Ventilanordnung | |
| BR9406893A (pt) | Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| AR049518A1 (es) | Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados | |
| DE60124387D1 (de) | Synergistische kombination zur behandlung von kolorektalkarzinom | |
| WO2006120681A3 (en) | Compositions and methods for skin care | |
| DE60142913D1 (de) | Arzneilösungen enthaltend modafinilverbindungen | |
| MXPA05010708A (es) | Composicion farmaceutica que comprende un inmunosupresor para utilizarse en el tratamiento de enfermedades de la piel. | |
| BR0113165A (pt) | Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados | |
| PA8525801A1 (es) | Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2 | |
| DE60310742D1 (de) | Extrakt mit antitumoraler und antitoxischer wirkung | |
| DE69927260D1 (de) | Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis | |
| TR199901385T2 (xx) | Piperidin t�revleri. | |
| WO2004006887A3 (en) | Composition and methods for the treatment of skin disorders | |
| SE0001916D0 (sv) | Novel formulation | |
| MX2007007015A (es) | Composiciones farmaceuticas para el tratamiento de celulitis. | |
| AR035988A1 (es) | Derivados de pirrolo-(3,4-b)quinoleina, su procedimiento de preparacion y su uso para la preparacion de medicamento | |
| HUP0204180A2 (hu) | Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére | |
| WO2004073627A3 (en) | Novel therapeutic method and compositions for topical administration | |
| AR109456A2 (es) | Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1259240 Country of ref document: EP |